Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Digital display
Synchronization of communication equipment
Adaptive analog echo/next cancellation
Method and apparatus for map transmission in wireless communication system
Fuse part in semiconductor device and method for forming the same
Compounds, compositions and use
Biodegradable aliphatic-aromatic copolyester for use in nonwoven webs
  Randomly Featured Patents
Signal processing for continuous analyte sensor
Rescue device
Settable digital CMOS differential sense amplifier
Solid, rapid-setting, rigid polyurethanes
Integrated circuit and sensor for imaging
Multiple image type photographing apparatus
Inspection line pans
Wheel or wheel cover
Apparatus for continuous heat treating advancing continuously formed pipe in a restricted space
Apparatus and method for dispensing defined portions of ice cream or a like deformable product